导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -15.33% | 922/1050 |
| 近一周 | -3.51% | 985/1104 |
| 近一月 | -6.33% | 891/1103 |
| 近一季 | -5.00% | 474/1092 |
| 近半年 | -19.16% | 987/1070 |
| 近一年 | -12.53% | 775/1018 |
| 近两年 | 39.79% | 596/926 |
| 近三年 | 28.32% | 415/834 |
| 成立以来 | 75.43% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-1.80% 627/1070 |
-15.23% 1020/1101 |
- - |
- - |
| 2025 | 37.23% 364/1065 |
6.92% 288/1014 |
4.41% 334/1038 |
19.75% 615/1050 |
2.65% 264/1065 |
| 2024 | 18.92% 100/1011 |
-0.48% 339/960 |
8.78% 26/983 |
13.87% 312/991 |
-3.53% 575/1011 |
| 2023 | -21.95% 719/952 |
-3.48% 762/880 |
-7.65% 678/895 |
-8.25% 514/915 |
-4.57% 458/952 |
| 2022 | -20.96% 366/867 |
-21.93% 635/773 |
15.98% 99/806 |
-26.58% 803/845 |
18.89% 25/867 |
| 2021 | -14.91% 514/740 |
-3.07% 273/580 |
8.02% 410/659 |
-14.74% 604/704 |
-4.68% 586/740 |
| 2020 | 47.22% 252/554 |
-8.03% 358/419 |
20.53% 278/466 |
6.90% 323/517 |
24.23% 78/554 |
| 2019 | 44.95% 185/410 |
27.24% 530/1146 |
-1.16% 452/1228 |
2.25% 272/390 |
12.73% 99/410 |
| 2018 | -27.85% 190/349 |
- - |
-8.77% 411/990 |
-6.23% 525/1000 |
-12.07% 586/1080 |
| 2017 | 29.75% 44/285 |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 汇丰晋信沪港深C VS. 东吴新产业精选股票A(580008) |